NCT00259805View on ClinicalTrials.gov

A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Chronic Focal EncephalitisRasmussen's Encephalitis
Interventions
DRUG

Rituximab

375 mg/m2 given as an IV infusion once weekly for four doses

Trial Locations (1)

94115

California Pacific Medical Center, San Francisco

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

California Pacific Medical Center Research Institute

OTHER